Detail Information of Microbiota Influence
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0267 Transporter Info | ||||
| Gene Name | SLC2A9 | ||||
| Transporter Name | Glucose transporter type 9 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Microbiota Influence of This DT (MBI) | |||||
|---|---|---|---|---|---|
|
Bacteria: Host unspecified microbiota |
|||||
|
Genus: Unknown microbiota |
|||||
|
Host unspecified microbiota |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
||||
|
Microbe Influence 1 |
Down regulating of SLC2A9 expression in hyperuricaemia condition | [1] | |||
|
Studied Phenotype |
Hyperuricaemia [ICD11: 5C55.Y] | ||||
|
Studied Tissue |
Kidney | ||||
|
In Vivo Model |
ICR specific-pathogen-free mice | ||||
|
Detailed Description |
The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC2A9. | ||||
| References | |||||
|---|---|---|---|---|---|
| 1 | The gut microbiota mediates the protective effects of anserine supplementation on hyperuricaemia and associated renal inflammation. Food Funct. 2021 Oct 4;12(19):9030-9042. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.